Clinical Topics

Weight, Not Diet, Associated With Higher Veteran Mortality From CRC

by U.S. Medicine

June 15, 2018

MINNEAPOLIS — While suspected, the relationship between dietary and lifestyle risk factors and long-term mortality from colorectal cancer remains poorly understood, according to a new study.

The report in the journal Digestive Diseases and Sciences pointed out that factors such as obesity, intakes of red meat and use of aspirin have all been linked to risk of colorectal cancer mortality, but not all studies have been able to replicate those findings.1

The study led by researchers from the Minneapolis VA Healthcare System and the University of Minnesota sought to add to the understanding of those associations. To do that, they focused on 46,551 participants In the Minnesota Colon Cancer Control Study. The subjects, 50-80 years old were randomly assigned to usual care (control) or annual or biennial screening by fecal occult blood testing.

Dietary intake and lifestyle risk factors were assessed by questionnaires at baseline, with colon cancer mortality assessed after 30 years of follow-up.

Increasing the risk of CRC mortality were age [hazard ratio (HR) 1.09; 95% CI 1.07, -1.11], male sex (HR 1.25; 95% CI 1.01, 1.57), and higher body mass index (BMI) (HR 1.03; 95% CI 1.00-1.05).

Undergoing screening for CRC was associated, however, with a reduced risk of colorectal cancer mortality (HR 0.76; 95% CI 0.61-0.94 and 0.67; 95% CI 0.53-0.83 for biennial and annual screening, respectively).

Intakes of grains, meats, proteins, coffee, alcohol, aspirin, fiber, fruits and vegetables were not found to be associated with colorectal cancer mortality, the researchers reported.

“Our study confirms the relationship between BMI and long-term colorectal cancer mortality,” the study authors concluded. “Modulation of BMI may reduce risk of CRC mortality.”


1Shaukat A, Dostal A, Menk J, Church TR. BMI Is a Risk Factor for Colorectal Cancer Mortality. Dig Dis Sci. 2017 Sep;62(9):2511-2517. doi: 10.1007/s10620-017-4682-z. Epub 2017 Jul 21. PubMed PMID: 28733869.

Comments are closed here.


Related Articles

Racial Disparities Found in BRCA Testing, Counseling

DURHAM, NC—Despite increases in BRCA mutation testing, racial/ethnic disparities in counseling and testing have persisted for decades, a study argued. The review published in the Journal of Racial and Ethnic Health Disparities said its purpose... View Article

VA Guideline Addresses Dental Management of Head/Neck Cancer Patients

SAN FRANCISCO—Few protocols have been published for the dental management of patients with head and neck cancer to prevent complications from head and neck radiation therapy, according to a new study.  The report in the... View Article


U.S. Medicine Recommends


More From oncology

Oncology

Racial Disparities Found in BRCA Testing, Counseling

DURHAM, NC—Despite increases in BRCA mutation testing, racial/ethnic disparities in counseling and testing have persisted for decades, a study argued. The review published in the Journal of Racial and Ethnic Health Disparities said its purpose... View Article

Oncology

VA Guideline Addresses Dental Management of Head/Neck Cancer Patients

SAN FRANCISCO—Few protocols have been published for the dental management of patients with head and neck cancer to prevent complications from head and neck radiation therapy, according to a new study.  The report in the... View Article

Oncology

Patients Treated with Thiopurines Have Higher Skin Cancer Mortality

PHILADELPHIA—Treatment with thiopurines is associated with an increased risk of squamous cell carcinoma of the skin in patients with inflammatory bowel diseases. An article in Clinical Gastroenterology and Hepatology discussed results of a study that... View Article

Oncology

Overcoming Radiation Resistant Prostate Cancer

LOS ANGELES—For nearly half of the patients with localized advanced prostate cancer, radiation therapy is the primary intervention and standard of care for recurrent disease following surgery. The problem is that nearly 30% to 50%... View Article

Oncology

JAK Enzymes Can Treat Leukemia, Lymphoma

NASHVILLE, TN—Precision oncology prescribes the use of molecularly-targeted therapy directed by identification of genomic alterations. A new study suggested the approach is particularly applicable to neoplasms that are resistant to standard cytotoxic chemotherapy, such as... View Article

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up